Treatment of abnormal uterine bleeding with gonadotropin-releasing hormone analogues.
Laufer
M R
MR
Department of Obstetrics and Gynecology, Brigham & Women's Hospital, Boston, MA 02115.
Rein
M S
MS
D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D002996:Clomiphene / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003276:Contraceptives, Oral / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004107:Dilatation and Curettage; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000150:complications; D006801:Humans; D007044:Hysterectomy; D008599:Menstruation Disturbances / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D011374:Progesterone / Q000627:therapeutic use
D003276:Contraceptives, Oral; D004967:Estrogens; D002996:Clomiphene; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone